Skip to main content

What the label lists and what reports show

Nadolol side effects

Nadolol's FDA label lists its adverse reactions in its own words. FAERS holds 7,532 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is macular degeneration (831 reports).

  • Generic listed

Check it at the source: the nadolol FDA label on DailyMed (effective May 12, 2026, Amneal Pharmaceuticals NY LLC); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

Most adverse effects have been mild and transient and have rarely required withdrawal of therapy. Cardiovascular Bradycardia with heart rates of less than 60 beats per minute occurs commonly, and heart rates below 40 beats per minute and/or symptomatic bradycardia were seen in about 2 of 100 patients. Symptoms of peripheral vascular insufficiency, usually of the Raynaud type, have occurred in approximately 2 of 100 patients. Cardiac failure, hypotension, and rhythm/conduction disturbances have each occurred in about 1 of 100 patients. Single instances of first degree and third degree heart block have been reported; intensification of AV block is a known effect of beta-blockers (see also CONTRAINDICATIONS , WARNINGS , and PRECAUTIONS ). Central Nervous System Dizziness or fatigue has been reported in approximately 2 of 100 patients; …

Source: FDA drug label, Amneal Pharmaceuticals NY LLC, effective May 12, 2026 (SPL set e2e24b14-0169-4028-828a-894ad3c2ba55), via openFDA; the full label on DailyMed

What do FAERS reports show?

7,532 reports list nadolol among the medicines taken, each a report of something that happened, not proof the medicine caused it; 612 are coded as a death and 2,577 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 22 reactions below, 6 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Drug Ineffective (a use or a product term, not a reaction)1,305
  • Macular Degeneration831
  • Nausea (named in the label)672
  • Headache (named in the label)603
  • Off Label Use (a use or a product term, not a reaction)603
  • Fatigue (named in the label)526
  • Pain513
  • Weight Decreased463
  • Diarrhoea (named in the label)442
  • Malaise419
  • Pyrexia403
  • Anaemia348
  • Dizziness (named in the label)340
  • Abdominal Pain323
  • Dyspnoea319
  • Constipation (named in the label)310
  • Therapeutic Product Effect Incomplete (a use or a product term, not a reaction)289
  • Dyspepsia284
  • Infusion Related Reaction268
  • Chronic Sinusitis265
  • Erythema265
  • Rectal Haemorrhage263
  • Asthenia255
  • Paraesthesia Oral245
  • Haematochezia240

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Nadolol: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions